Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioanalysis in the Age of New Drug Modalities.
Shi J, Chen X, Diao J, Jiang L, Li L, Li S, Liang W, Jin X, Wang Y, Wong C, Zhang XT, Tse FLS. Shi J, et al. Among authors: liang w. AAPS J. 2021 May 3;23(3):64. doi: 10.1208/s12248-021-00594-w. AAPS J. 2021. PMID: 33942188 Free PMC article. Review.
Detection of sivelestat and its metabolite in small volumes of plasma from Chinese ALI/ARDS patients with SIRS via high-throughput UPLC-MS/MS: A pharmacokinetic study.
Liu M, Zhang J, Dong L, Xue W, He Q, Liang W, Liu X, Zhang J, Gu L, Feng Y, Yang J, Wang H, Wang Y, Li K, Li Y, Kong W, Zhang X, Yao M, Wang K, Ma P, Zhang W. Liu M, et al. Among authors: liang w. J Pharm Biomed Anal. 2021 Feb 20;195:113876. doi: 10.1016/j.jpba.2020.113876. Epub 2020 Dec 30. J Pharm Biomed Anal. 2021. PMID: 33429252 Free PMC article.
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.
Xu Z, Wang Y, Liu Z, Zhang R, Zhou Y, Yu J, Lan J, Liang W, Liu G, Qu X, Chen J, Su Z, Yu S, Cheng Y, Wang W, Ren Q, Deng Q, Zhao Y, Yang H. Xu Z, et al. Among authors: liang w. Int Immunopharmacol. 2022 Aug;109:108780. doi: 10.1016/j.intimp.2022.108780. Epub 2022 Apr 20. Int Immunopharmacol. 2022. PMID: 35461158 Clinical Trial.
7,364 results